Blocking NF-κB signaling using an aurora kinase A inhibitor decreases the proliferation of epithelial ovarian cancer (EOC) stem cells by inducing cell-cycle arrest, which suggests that NF-κB inhibition may prevent recurrence and chemo-resistance in ovarian cancer [12]. The gene discussed is NFKB1; the disease is ovarian carcinoma.